Skip to main content
. 2020 Nov 17;12(2):8396. doi: 10.4081/hr.2020.8396

Table 1.

Patient characteristics.

Patient Gender Age (years) Location Size (mm) Therapy M-protein FLC ratio PET-CT R/P to MM Follow up (Months)
1 M 67 Oropharynx 30 Surgery neg neg neg No 16
2 M 49 Nasal 8 Surgery neg neg neg No 101
3 M 57 Nasal 40 Surgery neg neg neg No 14
4 M 63 Hypopharynx 15 Surgery neg neg ND No 51
5 M 57 Oropharynx 33 Radiotherapy IgG/lambda 5.2 g/L neg neg No 61
6 M 23 Lymph node 25 Surgery/ Radiotherapy neg neg neg No 26
7 F 64 Epipharynx 20 Surgery neg neg neg No 93
8 M 83 Nasal 15 Surgery neg neg neg No 4

M-protein=monoclonal protein; FLC=free light chains; MM=multiple myeloma, R/P to MM=recurrence or progression to multiple myeloma.